Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Kedudukan dalam Saham #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Harga Saham
$0.00060315
Disegerakkan terakhir: 2024-09-27
Modal Pasaran
$1.65M
Perubahan (1 hari)
19.64%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Amniotics AB (publ) (AMNI)

Kategori

Nisbah P/B bagi Amniotics AB (publ) (AMNI)
Nisbah P/B pada August 2026 TTM: 0.98
Menurut laporan kewangan dan harga saham terkini Amniotics AB (publ), nisbah P/B semasa (TTM) ialah 0.98. Pada akhir 2022, nisbah P/B syarikat ialah 43.73.
Sejarah nisbah P/B untuk Amniotics AB (publ) dari 2018 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 0.98 -40.17%
2023 1.63 -96.28%
2022 43.73 263.99%
2021 12.01 -34.02%
2020 18.21 -69.40%
2019 59.51 -75.80%
2018 245.87 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
6.3419 550.32%
US
6.2413 540.00%
NL
- -
CH
- -
KR
3.4612 254.92%
BE